Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Braz. j. infect. dis ; 25(3): 101586, 2021. tab, graf
Article in English | LILACS | ID: biblio-1339430

ABSTRACT

ABSTRACT Background: Vaccines in development against Group B Streptococcus (GBS) should contain the most prevalent capsular genotypes screened in the target population. In low- and middle-income countries epidemiological data on GBS carriage among pregnant women, a prerequisite condition for GBS neonatal sepsis, is needed to inform vaccine strategies. Objective: To investigate the prevalence of different GBS capsular genotypes that colonizes at-risk pregnant women in a private maternity hospital in São Paulo, Brazil. Methods: GBS strains isolated in routine maternity procedures from at-risk pregnant women from 2014 to 2018 were confirmed by mass spectrometry (MALDI-TOF) with subsequent DNA extraction for identification of capsular genotype through polymerase chain reaction (PCR). Demographic and gestational data were analyzed. Results: A total of 820 Todd-Hewitt broths positive for GBS were selected for streptococcal growth. Recovery and confirmation of GBS by MALDI-TOF were possible in 352. Strains were processed for determination of capsular genotype by PCR. From the total of 352 GBS isolates, 125 strains (35.5%) were genotyped as Ia; 23 (6.5%) as Ib; 41 (11.6%) as II; 36 (10.2%) as III; 4 (1.1%) as IV; 120 (34.1%) as V and 1 strain (0.3%) as VIII. Two isolates (0.7%) were not genotyped by used methodology. No statistically significant correlation between gestational risk factors, demographic data and distribution of capsular genotypes were found. Conclusions: GBS capsular genotypes Ia, Ib, II, III, and V were the most prevalent isolates colonizing at risk pregnant women in the present study. The inclusion of capsular genotypes Ia and V in the composition of future vaccines would cover 69.6% of capsular genotypes in the studied population. No statistically significant differences were observed between capsular genotype and gestational and demographic data and risk factors.


Subject(s)
Humans , Female , Pregnancy , Infant, Newborn , Pregnancy Complications, Infectious/epidemiology , Streptococcal Infections/epidemiology , Streptococcus , Streptococcus agalactiae/genetics , Brazil , Pregnant Women , Genotype
2.
Braz. j. infect. dis ; 6(2): 55-62, Apr. 2002.
Article in English | LILACS, SES-SP | ID: lil-332309

ABSTRACT

Group B Streptococcus (GBS) is the main etiological agent of neonatal sepsis in developed countries, however there is no detailed information on its incidence in Brazil. We registered the incidence and lethality of GBS infection in a Brazilian private maternity hospital from April 1991 to March 2000. Maternal risk factors contributing to neonatal infections were also scored. The rate of infection was determined by checking for GBS in the blood and liquor of symptomatic neonates within 72 hours of birth. Sepsis and/or early onset meningitis were diagnosed in 43 neonates (32 cases in blood, 1in liquor and 10 in blood and liquor). The overall incidence was 0.39 per thousand neonates and remained quite constant throughout the period, ranging from 0.25-0.63. Septic shock occurred in 33 neonates within 1 to 36 hours of birth (mean 15 hours). Among those patients, 26 (60) died between the 5th and the 85th hour after birth. Maternal risk factors, according to CDC criteria, included: gestational age below 37 weeks in 26 cases (60), amniorrhexis equal or superior to 18 hours in 7 cases (16), and maternal temperature equal or superior to 38(o)C in 4 cases (9). None of the mothers had received prophylactic antibiotics during labor nor were urine, rectal or vaginal swabs screened for GBS. Although the incidence of GBS infection in the population in this study was lower than that found in developed countries, its rate of mortality was higher. The death rate could be reduced through recognition of the risk factors and prophylactic antibiotics during labor.


Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Streptococcus , Sepsis , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/microbiology , Streptococcal Infections/epidemiology , Streptococcal Infections/microbiology , Time Factors , Birth Weight , Brazil , Incidence , Risk Factors , Gestational Age , Sepsis , Hospitals, Maternity , Shock, Septic/microbiology , Shock, Septic/mortality , Infant, Newborn, Diseases/mortality , Streptococcal Infections/drug therapy , Streptococcal Infections/mortality
3.
Rev. paul. pediatr ; 15(3): 159-62, set. 1997.
Article in Portuguese | LILACS | ID: lil-218886

ABSTRACT

Os autores descrevem e discutem três casos de infecçäo por Listeria mono cytogenes no período de janeiro de 1994 a dezembro de 1995, diagnosticados na Unidade Neonatal do Hospital e Maternidade Santa Joana, Säo Paulo. Nos três casos observamos líquido amniótico meconial. Em dois havia história materna de infecçäo de vias urinárias, fisometria e a idade gestacional (IG) era menor que 35 semanas. O quadro clínico nestes casos foi mais grave, evoluindo para óbito em menos de 24 horas. O terceiro recém-nascido(RN) tinha uma IG de 37 semanas, sem antecedentes de patologias maternas e a evoluçäo clínica foi satisfatória. É importante lembrar que o obstetra de estar atento para situaçöes de risco, já que o tratamento precoce da mäe pode modificar a...


Subject(s)
Humans , Male , Female , Infant, Newborn , Listeriosis/diagnosis , Risk Factors , Listeriosis/therapy
4.
AMB rev. Assoc. Med. Bras ; 37(4): 173-80, oct.-dec. 1991. tab
Article in Portuguese | LILACS | ID: lil-105636

ABSTRACT

Basedos em nossa experiência anterior na Instituiçäo para tratamento de crianças com câncer, febre (f+) e granulocitopenia (G+), selecionados dois diferentes regimes empíricos: ceftriaxona, uma vez ao dia, para o grupo de baixo risco (BR) - tumores sólidos e linfomas I e II -, e imipenem para o grupo de alto risco (AR) - leucemias e linfomas III e IV. Foram estudados 121 episódios de F+ e G+ em BR e 119 episódios em AR: o grupo AR teve 51,3% de infecçöes documentadas e o grupo BR, 58,7%. No grupo AR, os seguintes patógenos foram identificados nas hemoculturas: gram-positivos 52%, gram-negativos 20%. No grupo BR, 78% dos microorganismos isolados foram gram-positivos. Os patógenos mais comuns foran S. aureus, S. epidermidis, Enterobacter, P. mirabilis, E. coli. A incidência de hemoculturas positivas foi 21% para o grupo AR e 8,3% para o grupo BR. Superinfecçäo ocorreu em 23,5% no grupo AR e em 5,7% no grupo BR. O tempo médio de granulocitopenia foi 11,5% dias no grupo AR (mediano 8 dias) e 6,7 dias no grupo BR (mediano 6 diaas). Modificaçöes ao regime de antibioticoterapia empírica inicial ocorreram em 45,4% (AR) e 14,5% (BR) (associaçöes de anfotericina B, vancomicina e amicacina). Os índices de sucesso terapêutico foram de 97,6% (BR) e 94,2% (AR); para infecçöes documentadas, os índices foram 95,7% (BR) e 91,8% (AR). Os autores concluem que: 1§) a designaçäo de pacientes a dois grupos de risco permitiu confirmar a caracterizaçäo de duas populaçöes diferentes; 2§) imipenem como manoterapia inicial para o grupo AR mostrou-se extremamente eficaz, atingindo índices de sucesso terapêutico global de 94,2%; 3§) ceftriaxona no grupo BR também demonstrou alta eficácia; 4§) existe tendência a queda da incidência dos gram-negativos como agentes causais das superinfecçöes e elevaçäo significativa dos gram-positivos e fungos; 5§) os índices de sucesso terapêutico confirman a possibilidade de se utilizarem esquemas terapêuticos porgrupos de patologias, o que permite oferecer uma série de vantagens em termos de eficácia, diminuiçäo do risco de surgimento de resistência às drogas,custo do tratamento e conforto para os pacientes


Subject(s)
Child , Adolescent , Humans , Bacterial Infections/drug therapy , Ceftriaxone/therapeutic use , Fever/drug therapy , Imipenem/therapeutic use , Neoplasms/complications , Neutropenia/drug therapy , Bacterial Infections/etiology , Brazil , Fever/complications , Fungi/isolation & purification , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Leukemia/complications , Lymphoma/complications , Neoplasms/therapy , Neutropenia/complications
5.
Rev. Inst. Med. Trop. Säo Paulo ; 32(1): 6-10, jan.-fev. 1990. tab
Article in Portuguese | LILACS | ID: lil-89016

ABSTRACT

Materiais colhidos das presas, das bainhas das presas e do veneno de 15 Bothrops jararaca recém-capturadas, aparentemente saudáveis, foram submetidos a exame bacterioscópico e cultura aeróbica a anacróbia. As bactérias mais freqüentemente isoladas foram os estreptococos do grupo D (12 serpentes), Enterobacter sp. (6), Providencia rettgeri (6), Providencia sp. (4), Escherichia coli (4), Morganella morganii (3) e Clostridium sp. (5). Como estas bactérias säo semelhantes às encontradas nos abscessos de pacientes picados por serpentes do gênero Bothrops, é válido considerara a possibilidade de que bactérias da boca da serpente sejam inoculadas no momento da picada e, encontrando condiçöes favoráveis de multiplicaçäo, causem infecçäo


Subject(s)
Animals , Humans , Abscess/etiology , Crotalid Venoms , Mouth/microbiology , Snakes/microbiology , Bacteria/isolation & purification , Snake Bites/complications
6.
Folha méd ; 97(5/6): 297-307, nov.-dez. 1988. ilus, tab
Article in Portuguese | LILACS | ID: lil-82959

ABSTRACT

Após revisäo da literatura especializada, os autores relatam sua experiência com o esquema antimicrobiano ceftriaxona (100 mg/Kg/dia em dose única i.v.) mais amicacina (15mg/Kg/dia divididos em três doses i.v.) em 106 crianças submetidas a quimioterapia, que apresentaram 151 episódios de febre e granulocitopenia


Subject(s)
Infant , Child, Preschool , Child , Adolescent , Humans , Male , Female , Agranulocytosis/chemically induced , Amikacin/therapeutic use , Ceftriaxone/therapeutic use , Neoplasms/drug therapy , Amikacin/adverse effects , Ceftriaxone/adverse effects , Fever
SELECTION OF CITATIONS
SEARCH DETAIL